Episode 52: Scott Soleimanpour, MD, Associate Professor, Director of the Michigan Medicine Diabetes Transition Program, University of Michigan

<p>In this episode, Scott Soleimanpour joins us to discuss his fascinating research taking place at the University of Michigan. Dr. Soleimanpour provides details about a recent publication, <a href='https://pubmed.ncbi.nlm.nih.gov/33232298/'>Mitophagy protects β cells from inflammatory damage in diabetes. </a></p> <p>Dr. Soleimanpour's lab focuses on the molecular and genetic regulation of the mitochondrial life cycle, with a focus on mitophagy, a pathway to dispose of unhealthy or damaged mitochondria. Our studies also concentrate on novel genetic targets affecting the mitophagy pathway, which are also associated with diabetes in humans, through studies in cellular and mouse genetic model systems, as well as isolated human islets. </p> <p>To learn more about Soleimanpour's lab follow the link below:</p> <p><a href='https://medicine.umich.edu/dept/intmed/divisions/metabolism-endocrinology-diabetes/research/faculty-lab-websites/scott-soleimanpour-lab/research'>Soleimanpour Lab</a></p>